Finally, the multigene panel analysis performed in samples without evidence of BRCA deficiency allowed the identification of a patient with inherited ovarian cancer predisposition due to a RAD51C germline variant, with clinical and familial implications, which support the appropriateness of extending genetic testing to clinically meaningful genes other than BRCA1/2 in OC patients [23]. The gene discussed is BRCA1; the disease is ovarian carcinoma.